Moreover, technology in the management of diabetes, such as the integration between insulin pumps and CGM, which has led to automated insulin delivery system (AID), has been making optimal glucose control reachable by a larger number of patients than in the past (69), when only traditional multiple daily injection (MDI) therapy or stand-alone insulin pump (69) were available. This evidence concerns the gene INS and diabetes mellitus.